GRACEcast - Discussions with the Global Resource for Advancing Cancer Education

Spreaker is getting a new look!

Preview our new listening experience personalized just for you.

GRACEcast - Discussions with the Global Resource for Advancing Cancer Education - Cover Image

cancerGRACE

GRACEcast - Discussions with the Global Resource for Advancing Cancer Education

cancerGRACE

Medicine

GRACEcast - Discussions with the Global Resource for Advancing Cancer Education

RSS Feed

In this podcast series, the Global Resource for Advancing Cancer Education (GRACE) works to bring professionals together with patients and caregivers to work in partnership.

We interview patients, advocates and healthcare professionals to provide the most updated information for our community and to highlight important issues facing those dealing with a cancer diagnosis.

For more information visit www.cancerGRACE.org. To join the conversation, visit https://cancergrace.org/forums

In this podcast series, the Global Resource for Advancing Cancer Education (GRACE) works to bring professionals together with patients and caregivers to work in partnership. We interview patients, advocates and healthcare professionals to provide the most updated information for our community and to highlight important issues facing those dealing with a cancer diagnosis. For more information visit www.cancerGRACE.org. To join the conversation, visit https://cancergrace.org/forums read more read less

Listen on Spreaker App

↗

The Adaura Trial: The Effect on EGFR+ Treatment
Dr. Joshua Reuss discusses the ADAURA trial, which suggested Osimertinib as treatment for EGFR+ NSCLC.

15 Apr, 2024 - 06:25
Biomarker Driven Therapy for NSCLC
Dr. Aakash Desai discusses the administration of therapy for biomarkers, and how to overcome the gaps in administration, access, and affordability.

13 Apr, 2024 - 05:12
Current Recommendations and Best Practices for Biomarker Testing
Dr. Aakash Desai discusses the current recommendations for biomarker testing in patients with NSCLC, as well as best practices.

11 Apr, 2024 - 03:52
The Importance of Biomarker Testing: What is Liquid Biopsy?
Dr. Aakash Desai details the importance of biomarker testing, and discusses the method of liquid biopsy to do so.

9 Apr, 2024 - 04:54
Biomarkers in NSCLC
Dr. Aakash Desai gives a basic overview of biomarkers, and discusses which ones are important for patients with NSCLC.

8 Apr, 2024 - 05:54
Key Points from the Adaura Trial: Osimertinib
Dr. Joshua Reuss examines important details learned during the ADAURA trial, including overall survival, reduced risk of brain mets, and side effects.

30 Nov, 2023 - 06:13
Biomarkers in NSCLC
Dr. Aakash Desai gives a basic overview of biomarkers, and discusses which ones are important for patients with NSCLC.

23 Nov, 2023 - 05:54
The Importance of Biomarker Testing: What is Liquid Biopsy?
Dr. Aakash Desai details the importance of biomarker testing, and discusses the method of liquid biopsy to do so.

16 Nov, 2023 - 04:54
Barriers to Biomarker Testing: Cost and Insurance
Dr. Aakash Desai discusses how to address the issues of cost and insurance approval when obtaining biomarker testing.

9 Nov, 2023 - 03:29
Neoadjuvant Treatment for Patients with NSCLC
Dr. Joshua Reuss examines data on neoadjuvant targeted therapy.

27 Oct, 2023 - 03:10
There are no episodes.

Listen on Spreaker App

↗

Contacts

Spreaker is getting a new look!

GRACEcast - Discussions with the Global Resource for Advancing Cancer Education

GRACEcast - Discussions with the Global Resource for Advancing Cancer Education

For Creators

For Listeners & Advertisers

Choose Language

Follow us